| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| 180 Life Sciences Corp. | Director | Common Stock | 24,409 | $4,589 | $0.1880 | 04 Sep 2023 | Direct |
| 180 Life Sciences Corp. | Director | Non-Qualified Stock Option (right to buy) | 15,000 | 04 Sep 2023 | Direct | ||
| MERRIMACK PHARMACEUTICALS INC | Director | Common Stock | 0 | $13.35 | 31 Dec 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ATNF | 180 Life Sciences Corp. | 04 Sep 2023 | 2 | +$29,179 | 4 | Director | 08 Sep 2023, 16:00 |
| ATNF | 180 Life Sciences Corp. | 31 Oct 2022 | 1 | $0 | 4 | Director | 02 Nov 2022, 17:01 |
| ATNF | 180 Life Sciences Corp. | 27 Jul 2022 | 1 | $0 | 4 | Director | 29 Jul 2022, 16:17 |
| ATNF | 180 Life Sciences Corp. | 19 May 2022 | 2 | +$14,375 | 4/A | Director | 29 Jul 2022, 16:16 |
| ATNF | 180 Life Sciences Corp. | 14 Jan 2022 | 1 | +$14,373 | 4 | Director | 18 Jan 2022, 15:33 |
| /report/000089924322000473-ray-russell-t-2021-12-31 | MERRIMACK PHARMACEUTICALS INC | 31 Dec 2021 | 1 | -$3,840 | 4 | Director | 04 Jan 2022, 15:05 |
| ATNF | 180 Life Sciences Corp. | 04 Aug 2021 | 1 | $0 | 4 | Director | 05 Aug 2021, 16:18 |
| ATNF | 180 Life Sciences Corp. | 09 Jul 2021 | 0 | $0 | 3 | Director | 12 Jul 2021, 08:20 |
| /report/000089924321023538-ray-russell-t-2021-06-10 | MERRIMACK PHARMACEUTICALS INC | 10 Jun 2021 | 1 | $0 | 4 | Director | 14 Jun 2021, 16:05 |